Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study

References

• National Institute of Neurological Disorders and Stroke (NINDS). Migraine. https://www.ninds.nih.gov/Disorders/All-Disorders/Migraine-Information-Page.
   Google Scholar
• Law HZ, Chung MH, Nissan G, et al. Hospital burden of migraine in United States adults: a 15-year national inpatient sample analysis. Plast Reconstr Surg Glob Open. 2020;8(4):e2790. doi: 10.1097/GOX.0000000000002790.
   PubMedGoogle Scholar
• Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the United States: updated age, sex, and socioeconomic-specific estimates from government health surveys. Headache. 2021;61(1):60–68. doi: 10.1111/head.14024.
   PubMed Web of Science ®Google Scholar
• Burch RC, Buse DC, Lipton RB. Migraine: epidemiology, burden, and comorbidity. Neurol Clin. 2019;37(4):631–649. doi: 10.1016/j.ncl.2019.06.001.
   PubMed Web of Science ®Google Scholar
• Eigenbrodt AK, Ashina H, Khan S, et al. Diagnosis and management of migraine in ten steps. Nat Rev Neurol. 2021;17(8):501–514. doi: 10.1038/s41582-021-00509-5.
   PubMed Web of Science ®Google Scholar
• Ailani J, Burch RC, Robbins MS. The American headache society consensus statement: update on integrating new migraine treatments into clinical practice. Headache. 2021;61(7):1021–1039. doi: 10.1111/head.14153.
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Holland S, Freitag F, et al. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the quality standards subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78(17):1337–1345. doi: 10.1212/WNL.0b013e3182535d20.
   PubMed Web of Science ®Google Scholar
• Hepp Z, Dodick DW, Varon SF, et al. Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: a retrospective claims analysis. Cephalalgia. 2017;37(5):470–485. doi: 10.1177/0333102416678382.
   PubMed Web of Science ®Google Scholar
• Kawata AK, Shah N, Poon JL, et al. Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: results from the assessment of TolerabiliTy and effectiveness in MigrAINe patients using preventive treatment (ATTAIN) study. Headache. 2021;61(3):438–454. doi: 10.1111/head.14053.
   PubMed Web of Science ®Google Scholar
• Bigal ME, Serrano D, Buse D, et al. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache. 2008;48(8):1157–1168. doi: 10.1111/j.1526-4610.2008.01217.x.
   PubMed Web of Science ®Google Scholar
• Ferreira A, Marques SR, Lopes S, et al. Preventive oral treatment in migraine: efficacy and dropout rates observed at a tertiary headache center. SN Compr Clin Med. 2022;5(1):38. doi: 10.1007/s42399-022-01369-w.
   Google Scholar
• Mavridis T, Deligianni CI, Karagiorgis G, et al. Monoclonal antibodies targeting CGRP: from clinical studies to real-world evidence–what do we know so far? Pharmaceuticals. 2021;14(7):700. doi: 10.3390/ph14070700.
   Web of Science ®Google Scholar
• Varnado OJ, Manjelievskaia J, Ye W, et al. Treatment patterns for calcitonin gene-related peptide monoclonal antibodies including galcanezumab versus conventional preventive treatments for migraine: a retrospective US claims study. Patient Prefer Adherence. 2022;16:821–839. doi: 10.2147/PPA.S346660.
   PubMed Web of Science ®Google Scholar
• Market Clarity Data. 2007–2022. [Internet]. https://www.optum.com/business/life-sciences/real-world-data/market-clarity-data.html.
   Google Scholar
• Healthcare Cost and Utilization Project (HCUP). Clinical Classifications Software (CCS) for ICD-9-CM [Internet]. 2017. http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp.
   Google Scholar
• Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–682. doi: 10.1093/aje/kwq433.
   PubMed Web of Science ®Google Scholar
• Bigal ME, Lipton RB. Excessive acute migraine medication use and migraine progression. Neurology. 2008;71(22):1821–1828. doi: 10.1212/01.wnl.0000335946.53860.1d.
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Olesen J, Bousser MG, et al. The international classification of headache disorders, 2nd edition (ICHD-II)–revision of criteria for 8.2 medication-overuse headache. Cephalalgia. 2005;25(6):460–465. doi: 10.1111/j.1468-2982.2005.00878.x.
   PubMed Web of Science ®Google Scholar
• Pharmacy Quality Alliance (PQA). One new health plan performance measure and two new pharmacy measures recommended for endorsement. https://www.pqaalliance.org/assets/docs/PQA_Summary-KeyPoints_Endorse_MPT_SP-TAT_PDC-CMP-PH.pdf.
   Google Scholar
• Pharmacy Quality Alliance (PQA). Measure overview and rationale: migraine preventive therapy (MPT) 2021. https://www.pqaalliance.org/assets/docs/PQA_MPT_Rationale.pdf.
   Google Scholar
• Biscetti L, De Vanna G, Cresta E, et al. Headache and immunological/autoimmune disorders: a comprehensive review of available epidemiological evidence with insights on potential underlying mechanisms. J Neuroinflammation. 2021;18(1):259. doi: 10.1186/s12974-021-02229-5.
   PubMed Web of Science ®Google Scholar
• Lin WS, Huang TF, Chuang TY, et al. Association between cervical spondylosis and migraine: a nationwide retrospective cohort study. Int J Environ Res Public Health. 2018;15(4):587. doi: 10.3390/ijerph15040587.
   PubMed Web of Science ®Google Scholar
• Vivekanantham A, Edwin C, Pincus T, et al. The association between headache and low back pain: a systematic review. J Headache Pain. 2019;20(1):82. doi: 10.1186/s10194-019-1031-y.
   PubMedGoogle Scholar
• Yoon MS, Manack A, Schramm S, et al. Chronic migraine and chronic tension-type headache are associated with concomitant low back pain: results of the German headache consortium study. Pain. 2013;154(3):484–492. doi: 10.1016/j.pain.2012.12.010.
   PubMed Web of Science ®Google Scholar
• Blumenfeld AM, Bloudek LM, Becker WJ, et al. Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the second international burden of migraine study (IBMS-II). Headache. 2013;53(4):644–655. doi: 10.1111/head.12055.
   PubMed Web of Science ®Google Scholar
• Parikh SK, Silberstein SD. Current status of antiepileptic drugs as preventive migraine therapy. Curr Treat Options Neurol. 2019;21(4):16. doi: 10.1007/s11940-019-0558-1.
   PubMed Web of Science ®Google Scholar
• Abu-Zaid A, AlBatati SK, AlHossan AM, et al. Galcanezumab for the management of migraine: a systematic review and Meta-Analysis of randomized Placebo-Controlled trials. Cureus. 2020;12(11):e11621. doi: 10.7759/cureus.11621.
   PubMed Web of Science ®Google Scholar
• DiGrande S. The current landscape of CGRP inhibitor coverage. 2019. https://www.ajmc.com/view/the-current-landscape-of-cgrp-inhibitor-coverage.
   Google Scholar
• Al-Hassany L, Lyons HS, Boucherie DM, et al. The sense of stopping migraine prophylaxis. J Headache Pain. 2023;24(1):9. doi: 10.1186/s10194-023-01539-8.
   PubMed Web of Science ®Google Scholar
• Raffaelli B, Terhart M, Overeem LH, et al. Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort study. Cephalalgia. 2022;42(4–5):326–334. doi: 10.1177/03331024211046617.
   PubMed Web of Science ®Google Scholar
• Vernieri F, Brunelli N, Messina R, et al. Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study. J Headache Pain. 2021;22(1):154. doi: 10.1186/s10194-021-01363-y.
   PubMed Web of Science ®Google Scholar
• Seng EK, Rains JA, Nicholson RA, et al. Improving medication adherence in migraine treatment. Curr Pain Headache Rep. 2015;19(6):24. doi: 10.1007/s11916-015-0498-8.
   PubMed Web of Science ®Google Scholar